Uneven Implementation of Nirsevimab Prophylaxis Resulted in Non-Uniform Reductions in RSV-Related Hospitalizations in Italy
Timely and universal administration of nirsevimab significantly reduced RSV hospitalizations and severity, while delayed implementation resulted in limited benefit. These findings support early and uniform prophylaxis to mitigate health disparities and seasonal pressure on pediatric healthcare systems.
Authors
- M. Fornaro
- Claudio Cafagno (ORCID: https://orcid.org/0000-0003-3951-1679)
- Letizia Lorusso (ORCID: https://orcid.org/0000-0002-2058-9284)
- Anthea Mariani
- Desireé Caselli (ORCID: https://orcid.org/0000-0002-5716-3703)
- Giulia Marozzi
- Enrico Valletta
- Maurizio Aricò (ORCID: https://orcid.org/0000-0002-1908-6671)
- Melodie O. Aricò (ORCID: https://orcid.org/0000-0003-2072-3559)
- Daniela Trotta
- Francesco Accomando (ORCID: https://orcid.org/0000-0002-3205-106X)
- Claudia Rossini
Institutions
- University of Siena (IT)
- ASL Roma (IT)
- Azienda Unità Sanitaria Locale Della Romagna (IT)
- Ospedale G.B. Morgagni - L.Pierantoni (IT)
- Azienda Socio Sanitaria Territoriale Lariana (IT)
- Ospedale Pediatrico Giovanni XXIII (IT)
- Azienda USL di Pescara (IT)
- University of Macerata (IT)
- University of Bari Aldo Moro (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Infectious Disease Reports
- Published
- 2025-09-12
- DOI
- https://doi.org/10.3390/idr17050115
- Citations
- 4
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 5.42